Quick10K

⚲

Calamp

Filings

10-Q	2021-05-31	Filed 2021-06-25
10-K	2021-02-28	Filed 2021-04-22
10-Q	2020-11-30	Filed 2020-12-17
10-Q	2020-08-31	Filed 2020-09-24
10-Q	2020-05-31	Filed 2020-06-25
10-K	2020-02-29	Filed 2020-05-06
10-Q	2019-11-30	Filed 2019-12-19
10-Q	2019-08-31	Filed 2019-09-26
10-Q	2019-05-31	Filed 2019-06-28
10-K	2019-02-28	Filed 2019-05-01
10-Q	2018-11-30	Filed 2018-12-20
10-Q	2018-08-31	Filed 2018-09-27
10-Q	2018-05-31	Filed 2018-06-28
10-K	2018-02-28	Filed 2018-05-10
10-Q	2017-11-30	Filed 2017-12-21
10-Q	2017-08-31	Filed 2017-09-28
10-Q	2017-05-31	Filed 2017-06-27
10-K	2017-02-28	Filed 2017-05-15
10-Q	2016-11-30	Filed 2016-12-21
10-Q	2016-08-31	Filed 2016-09-29
10-Q	2016-05-31	Filed 2016-06-29
10-K	2016-02-29	Filed 2016-04-20
10-Q	2015-11-30	Filed 2015-12-22
10-Q	2015-08-31	Filed 2015-10-01
10-Q	2015-05-31	Filed 2015-06-30
10-K	2015-02-28	Filed 2015-04-21
10-Q	2014-11-30	Filed 2014-12-23
10-Q	2014-08-31	Filed 2014-10-06
10-Q	2014-05-31	Filed 2014-07-01
10-K	2014-02-28	Filed 2014-04-24
10-Q	2013-08-31	Filed 2013-10-02
10-Q	2013-05-31	Filed 2013-06-27
10-K	2013-02-28	Filed 2013-04-25
10-Q	2012-11-30	Filed 2012-12-20
10-Q	2012-08-31	Filed 2012-09-25
10-Q	2012-05-31	Filed 2012-06-28
10-K	2012-02-28	Filed 2012-04-26
10-Q	2011-11-26	Filed 2011-12-22
10-Q	2011-08-27	Filed 2011-09-29
10-Q	2011-05-28	Filed 2011-06-30
10-K	2011-02-28	Filed 2011-04-28
10-Q	2010-11-27	Filed 2011-01-04
10-Q	2010-08-28	Filed 2010-10-06
10-Q	2010-05-29	Filed 2010-07-08
10-K	2010-02-28	Filed 2010-05-06
10-Q	2009-11-28	Filed 2010-01-07

Reports

8-K	2020-09-24
8-K	2020-08-24
8-K	2020-07-29
8-K	2020-07-02
8-K	2020-06-25
8-K	2020-05-28
8-K	2020-05-05
8-K	2020-04-24
8-K	2020-04-21
8-K	2020-04-15
8-K	2020-03-27
8-K	2020-03-20
8-K	2020-03-05
8-K	2020-01-29
8-K	2020-01-09
8-K	2019-11-30
8-K	2019-11-26
8-K	2019-11-04
8-K	2019-10-24
8-K	2019-10-23
8-K	2019-09-30
8-K	2019-08-31
8-K	2019-07-24
8-K	2019-05-31
8-K	2019-05-28
8-K	2019-04-30
8-K	2019-04-12
8-K	2019-04-08
8-K	2019-03-19
8-K	2019-02-28
8-K	2019-02-28
8-K	2019-02-25
8-K	2018-12-10
8-K	2018-12-06
8-K	2018-11-30
8-K	2018-09-27
8-K	2018-08-01
8-K	2018-07-25
8-K	2018-07-20
8-K	2018-07-17
8-K	2018-07-16
8-K	2018-06-27
8-K	2018-05-07
8-K	2018-04-26
8-K	2018-03-30

Calamp Financials

CAMP Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin


Comps ($MM TTM)	Market Cap	Gross Margin	EV/EBITDA	Ret on Assets	Assets	Liabilities	Revenue	G Profit	Net Income	EBITDA	EV
Aries I Acquisition Corp. (RAMMU)
024 Pharma (EEIG)
Beauty Health Co (VSPRW)
Aquarius I Acquisition Corp. (AQUI)
MIZUHO FINANCIAL GROUP INC (MZHOF)
Eucrates Biomedical Acquisition Corp. (EUCRW)
11 Good Energy (ELVN)
180 Life Sciences Corp. (ATNFW)
1347 Capital Corp (TFSC)
Avanti Acquisition Corp. (AVAN-WT)
CORDIA CORP (CORG)
FCCC INC (FCIC)
Biofrontera Inc. (BFRI)
Ameren Illinois Co (AILNP)
MITSUBISHI UFJ FINANCIAL GROUP INC (MBFJF)
Janus International Group, Inc. (JBI-WT)
23andMe Holding Co. (MEUSW)
OceanTech Acquisitions I Corp. (OTECU)
Palayan Resources, Inc. (PLYN)
ALABAMA POWER CO (APRCP)


Balance Sheet ($MM)	2011-08-27	2011-11-26	2012-02-28	2012-05-31	2012-08-31	2012-11-30	2013-02-28	2013-05-31	2013-08-31	2013-11-30	2014-02-28	2014-05-31	2014-08-31	2014-11-30	2015-02-28	2015-05-31	2015-08-31	2015-11-30	2016-02-29	2016-05-31	2016-08-31	2016-11-30	2017-02-28	2017-05-31	2017-08-31	2017-11-30	2018-02-28	2018-05-31	2018-08-31	2018-11-30	2019-02-28	2019-05-31	2019-11-30
Cash	4	4	6	7	10	14	63	24	30	31	19	22	23	24	34	116	100	107	139	67	95	75	94	109	127	138	133	170	274	272	256	190	102
Accounts Receivable	15	16	14	19	20	21	19	26	28	31	37	35	38	45	48	45	46	45	49	69	69	67	67	66	64	70	72	70	71	72	78	74	83
Inventory	12	12	10	15	13	13	14	12	14	13	15	15	20	20	19	16	23	18	17	28	28	31	29	33	31	39	36	33	31	32	32	42	44
PP&E	2	2	2	2	2	3	19	4	4	4	23	6	7	7	31	11	11	11	11	19	22	22	21	21	21	21	21	21	22	23	27	55	57
Assets	54	54	51	67	69	73	151	160	166	165	179	181	191	198	203	360	372	370	384	426	420	403	408	427	446	475	473	493	611	608	604	652	562
Accounts Payable	14	12	10	18	14	13	12	16	20	17	21	20	29	30	24	26	33	25	25	36	37	33	30	34	35	42	35	43	36	32	40	33	37
Long-Term Debt	3	3	3	6	6	5	5	8	7	2	2	2	1	1	1	135	137	138	140	141	143	145	147	149	151	152	154	156	269	272	276	298	273
Liabilities	34	31	27	37	34	33	33	40	44	38	46	44	52	55	51	187	196	189	195	237	239	234	245	253	260	274	274	291	401	406	398	453	372
Stockholders' Equity	20	23	25	30	34	39	118	120	122	128	133	137	138	144	151	174	176	182	189	189	181	168	163	174	186	201	199	202	210	202	206	199	191


Income Statement ($MM)	2011-08-27	2011-11-26	2012-02-28	2012-05-31	2012-08-31	2012-11-30	2013-02-28	2013-05-31	2013-08-31	2013-11-30	2014-02-28	2014-05-31	2014-08-31	2014-11-30	2015-02-28	2015-05-31	2015-08-31	2015-11-30	2016-02-29	2016-05-31	2016-08-31	2016-11-30	2017-02-28	2017-05-31	2017-08-31	2017-11-30	2018-02-28	2018-05-31	2018-08-31	2018-11-30	2019-02-28	2019-05-31	2019-11-30
Revenue	34	33	38	44	44	44	48	54	68	64	60	59	59	63	69	65	70	75	71	91	90	83	86	88	90	94	94	95	96	88	84	89	97
Cost of Revenue	22	23	27	30	30	30	33	35	44	43	39	39	39	41	4	42	45	48	43	56	61	48	50	51	55	55	56	57	56	52	51	54	60
Gross Profit	12	10	11	14	14	14	15	18	24	21	21	20	20	22	25	24	25	27	28	35	46	35	36	37	39	38	38	38	40	36	33	35	37
R&D	3	3	3	3	4	4	4	5	7	5	5	5	5	5	5	5	5	5	5	6	7	5	5	6	7	6	7	7	8	7		7	8
SG&A	6	5	6	6	6	6	7	9	11	8	9	9	9	9	9	10	11	11	16	27	40	24	31	29	28	24	14	26	25	24		32	29
Tax	0	0	0	0	0	0	-29	1	2	2	-0	2	2	2	2	2	2	3	-2	0	1	0	-1	0	4	3	2	2	1	0		-2	-3
Net Income	1	2	2	4	4	4	33	2	3	4	3	3	3	4	7	4	3	4	6	-3	1	-2	-4	-3	12	12	-5	9	-1	-1	11	-9	-7


Cash Flow ($MM)	2011-08-27	2011-11-26	2012-02-28	2012-05-31	2012-08-31	2012-11-30	2013-02-28	2013-05-31	2013-08-31	2013-11-30	2014-02-28	2014-05-31	2014-08-31	2014-11-30	2015-02-28	2015-05-31	2015-08-31	2015-11-30	2016-02-29	2016-05-31	2016-08-31	2016-11-30	2017-02-28	2017-05-31	2017-08-31	2017-11-30	2018-02-28	2018-05-31	2018-08-31	2018-11-30	2019-02-28	2019-05-31	2019-11-30
Cash Operating		2	5	3	4	4	6	6	8		3	7	8		8	16	12	9	10	8	11	0		11		23		31	6	11		-6	4
Cash Investing		-0	-0	-1	-0	-0	-0	-47	-0	-1	-16	-5	-3	-4	3	-85	-26		23	-81	26	-6		4		-12		12	-27	-3		-61	-0
Cash Financing		-2	-3	-0	-1	0	44	3	-2		1	0	-4		-0	151	-3	-0	0	1	-10	-14		-0		-0		-6	125	-11		-0	-95